newsfilter
← Latest News
Business Wire·

Silence Therapeutics to Participate in Jefferies Global Healthcare Conference

Silence Therapeutics plc (NASDAQ:SLN), a global clinical-stage biotechnology company developing novel siRNA (short interfering RNA) therapies, today announced that management will participate in an analyst-led fireside